News - Page 175 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Silo Wellness Partners with Mushe Inc. to Establish First Legal Brick & Mortar Psychedelic and Functional Mushroom Shop in the Western Hemisphere

Silo Wellness Partners with Mushe Inc. to Establish First Legal Brick & Mortar Psychedelic and Functional Mushroom Shop in the Western Hemisphere

Post published:June 2, 2021
Post category:Press Release

Read more about the article Cybin Announces Sponsorship of a Kernel Flow Feasibility Study to Measure Ketamine’s Psychedelic Effects on Cerebral Cortex Hemodynamics

Cybin Announces Sponsorship of a Kernel Flow Feasibility Study to Measure Ketamine’s Psychedelic Effects on Cerebral Cortex Hemodynamics

Post published:June 1, 2021
Post category:Press Release

Read more about the article PharmaTher and TSRL Enter into Co-Development Agreement For Microneedle Patch Delivery Technology for Psychedelics and Antivirals

PharmaTher and TSRL Enter into Co-Development Agreement For Microneedle Patch Delivery Technology for Psychedelics and Antivirals

Post published:June 1, 2021
Post category:Press Release

Read more about the article Small Pharma Inc. Expands Phase I/IIa Clinical Trial With Additional Study Site

Small Pharma Inc. Expands Phase I/IIa Clinical Trial With Additional Study Site

Post published:June 1, 2021
Post category:Press Release

Read more about the article MYND Life Sciences announces Depression Biomarker Diagnostic Program

MYND Life Sciences announces Depression Biomarker Diagnostic Program

Post published:June 1, 2021
Post category:Press Release

Read more about the article Psychedelics and Cannabis ETF Launches on NYSE Arca in First for the U.S.

Psychedelics and Cannabis ETF Launches on NYSE Arca in First for the U.S.

Post published:June 1, 2021
Post category:News

Read more about the article Horizons ETFs Announces Methodology Update for the North American Psychedelics Index

Horizons ETFs Announces Methodology Update for the North American Psychedelics Index

Post published:May 31, 2021
Post category:Press Release

Read more about the article Filament Health Partners with TrPR Psychedelic Research Program at UCSF to Advance First Drug Candidates Through FDA Phase 1 and Phase 2 Clinical Trials

Filament Health Partners with TrPR Psychedelic Research Program at UCSF to Advance First Drug Candidates Through FDA Phase 1 and Phase 2 Clinical Trials

Post published:May 31, 2021
Post category:Press Release

Read more about the article Psychedelic Bulletin: COMPASS Pathways’ 4th Patent; MagicMed to Be Acquired; MindMed Insider Selling

Psychedelic Bulletin: COMPASS Pathways’ 4th Patent; MagicMed to Be Acquired; MindMed Insider Selling

Post published:May 30, 2021
Post category:Psychedelic Bulletin

Read more about the article MYND Life Sciences Inc. Establishes Scientific Advisory Board

MYND Life Sciences Inc. Establishes Scientific Advisory Board

Post published:May 28, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.